Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours Β· Estimated delivery Aug 9 - Aug 14
Access comprehensive market data, trends, and forecasts in one downloadable databook: Market Overview: Novel Use in Different Areas A class of drugs used in the management of type 2 diabetes and obesity is called GLP-1 receptor agonists
Cell (2013) 155(4):75064
PubMed, den Heijer, M., et al
The weight loss medication is an alternative to GLP-1 injections
52 In a phase 1b trial done to evaluate the safety, pharmacokinetics and pharmacodynamics of orforglipron in patients with T2DM, orforglipron resulted in significant reductions in HbA1c, fasting blood glucose and body weight, with an adverse event profile consistent with that of other GLP-1RA
US$ 25.09
US$ 21.53
US$ 24.62
US$ 24.86
US$ 29.45
US$ 22.19
